Recro Pharma’s Competitors, Revenue, Number of Employees, Funding, Acquisitions & News

Recro Pharma is a specialty pharmaceutical company that focuses on developing medical products for hospitals and other acute care settings. Read more

Gerri Henwood's photo - President & CEO of Recro Pharma

President & CEO

Gerri Henwood

CEO Approval Rating

94/100

Founded:

2007

Status:

PublicNASDAQREPH

Annual Revenue
Employees
Sector

- -

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Durect is Recro Pharma's biggest rival. Durect was founded in Cupertino, California} in 1998. Durect operates in the Pharmaceuticals industry. Compared to Recro Pharma, Durect generates $30.1M less revenue.

Purdue is Recro Pharma's #2 rival. Purdue's headquarters is in Stamford, Connecticut, and was founded in 1991. Purdue competes in the Pharmaceuticals field. Purdue generates 3,740% of Recro Pharma's revenue.

Semnur Pharmaceuticals is Recro Pharma's #3 competitor. Semnur Pharmaceuticals was founded in 2013 in Mountain View, California. Semnur Pharmaceuticals operates in the Pharmaceuticals industry. Semnur Pharmaceuticals generates $77.7M less revenue than Recro Pharma.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Centrexion Therapeutics a competitor of Recro Pharma?

Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$80.2M

Recro Pharma's revenue is the ranked 8th among it's top 10 competitors. The top 10 competitors average 712M. Over the last four quarters, Recro Pharma's revenue has decreased by 38.5%. Specifically, in Q2 2020's revenue was $15.5M; in Q1 2020, it was $21.8M; in Q4 2019, it was $21M; in Q3 2019, Recro Pharma's revenue was $25.3M.

Acquisitions

No recent acquisitions found related to Recro Pharma

Recro Pharma Funding History

$30M$53.8M$153.8M$160.2M

Since Recro Pharma was founded in 2007, it has participated in 6 rounds of funding. In total Recro Pharma has raised $160.2M. Recro Pharma's last funding round was on May 2020 for a total of $4.4M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Debt - PPP (CARES Act)
May 2020
$4.4M
Debt - PPP (CARES Act)
May 2020
$2M - $5M

U.S. Small Business Administration.

Debt
Nov 2017
$100M
Equity
Jun 2015
$16M
Convertible Note
Apr 2015
$7.8M
-

Total Funding: $160.2M

Since Recro Pharma was founded in 2007, it has participated in 6 rounds of funding. In total Recro Pharma has raised $160.2M. Recro Pharma's last funding round was on May 2020 for a total of $4.4M

Investments

No recent investments found related to Recro Pharma

Recro Pharma News

May 12, 2020SEC

Recro Pharma, Inc. received Paycheck Protection Program Loan

Recro Pharma, Inc. received Paycheck Protection Program Loan... See more »
May 1, 2020Benzinga

Recro Announces Change in Location of its 2020 Annual Meeting of Shareholders to its Corporate Headquarters

MALVERN, Pa., May 01, 2020 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (NASDAQ:REPH) (the "Company"), a hi... See more »
April 21, 2020DirectorsTalk Interviews

Recro Pharma - Consenus Indicates Potential 121.9% Upside

Recro Pharma with ticker code (REPH) now have 4 analysts covering the stock with the consensus sugges... See more »
April 18, 2020DirectorsTalk Interviews

Recro Pharma - Consenus Indicates Potential 107.9% Upside

Recro Pharma found using ticker (REPH) have now 4 analysts covering the stock with the consensus sugg... See more »
April 12, 2020DirectorsTalk Interviews

Recro Pharma - Consenus Indicates Potential 126.7% Upside

Recro Pharma found using ticker (REPH) now have 4 analysts covering the stock with the consensus sugg... See more »
March 4, 2020BioSpace

Recro Reports Financial Results for the Year Ended 2019

Recro Pharma, Inc. (Nasdaq:REPH), a high-performing, revenue generating contract development and manu... See more »

Recro Pharma Press Releases

December 10, 2018StreetInsider

Recro Pharma Announces Presentation of New Data Demonstrating IV Meloxicam's Effect on Platelet Function at the 72nd PostGraduate Assembly in Anesthesiology

Recro Pharma, Inc. (NASDAQ: REPH), a revenue generating specialty pharmaceutical company focused on t... See more »
December 10, 2018StreetInsider

Recro Pharma Announces Presentation of New Data Demonstrating IV Meloxicam's Effect on Platelet Function at the 72nd PostGraduate Assembly in Anesthesiology

Recro Pharma, Inc. (NASDAQ: REPH), a revenue generating specialty pharmaceutical company focused on t... See more »
November 5, 2018Business Wire

Recro Gainesville Adds New Facility, Broadens Capabilities With High-Potent Processing on Deck

GAINESVILLE, Ga.--(BUSINESS WIRE)--Recro Gainesville has added a 24,000-square-foot facility near its... See more »
October 1, 2018GlobeNewswire

Recro Announces Expansion of CDMO Service Capabilities

MALVERN, Pa., Oct. 01, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (NASDAQ:REPH), a revenue generatin... See more »
July 27, 2018MarketersMedia

The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Recro Pharma, Inc. and Reminds Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / July 27, 2018 / The Schall Law Firm, a national shareholder rights lit... See more »
July 22, 2018GlobalNewswire

Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

NEW YORK, July 22, 2018 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP announces that class action lawsuit... See more »
March 29, 2018GlobalNewswire

Recro Pharma Announces Commercial Team Additions

MALVERN, Pa., March 29, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generati... See more »

Headquarters

490 Lapp Rd

Malvern, Pennsylvania19355

1-484-395-2470

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Recro Pharma is a specialty pharmaceutical company that focuses on developing medical products for hospitals and other acute care settings. Recro Pharma was founded in 2007. Recro Pharma's headquarters is located in Malvern, Pennsylvania, USA 19355. I...

CEO

Recro Pharma's President & CEO, Gerri Henwood, currently has an approval rating of 94%. Recro Pharma's primary competitors are Durect, Purdue & Semnur Pharmaceuticals.

Website

recropharma.com

Frequently Asked Questions about Recro Pharma

  1. When was Recro Pharma founded?

    Recro Pharma was founded in 2007
  2. Who is Recro Pharma's CEO?

    Recro Pharma's CEO is Gerri Henwood
  3. How much revenue does Recro Pharma generate?

    Recro Pharma generates $80.2M in revenue
  4. How much funding does Recro Pharma have?

    Recro Pharma has historically raised $160.2M in funding
  1. Where is Recro Pharma's headquarters?

    Recro Pharma's headquarters is in Malvern Pennsylvania, USA
  2. How many employees does Recro Pharma have?

    Recro Pharma has 255 employees
  3. Who are Recro Pharma's competitors?

    Recro Pharma's top competitors are Durect, Purdue, Semnur Pharmaceuticals